Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2015

Jul 9, 2015

34117_dirs_2015-07-09_e2b0aab6-824f-4f5b-81ba-683ec44f54c9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUSD)
CIK: 0000715446
Period of Report: 2015-07-07

Reporting Person: JOHNSON BRUCE F (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-07-07 Common Stock P 6500 $3.62 Acquired 375587 Direct

Footnotes

F1: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.55 to $3.79, inclusive. The reporting person undertakes to provide to ITUS Corporation, any security holder of ITUS Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.